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Cellular splicing factor UAP56 
stimulates trimeric NP formation 
for assembly of functional influenza 
viral ribonucleoprotein complexes
Yifan Hu1, Vishal Gor1, Kazuya Morikawa1,2, Kyosuke Nagata2 & Atsushi Kawaguchi1,2,3
The influenza virus RNA genome exists as a ribonucleoprotein (RNP) complex by interacting with NP, 
one of virus-encoded RNA binding proteins. It is proposed that trimeric NP is a functional form, but it is 
not clear how trimeric NP is formed and transferred to RNA. UAP56, a cellular splicing factor, functions 
as a molecular chaperone for NP and is required for the replication-coupled RNP formation of newly 
synthesized viral genome, but the details of NP transfer to viral RNA by UAP56 is unclear. Here we 
found that UAP56 is complexed with trimeric NP, but not monomeric NP. Gel filtration analysis and 
atomic force microscopy analysis indicated that the complex consists of two trimeric NP connected 
by UAP56. We also found that UAP56 stimulates trimeric NP formation from monomeric NP even at 
physiological salt concentrations. Thus, UAP56 facilitates the transfer of NP to viral RNA since trimeric 
NP has higher RNA binding activity than monomeric NP. Further, UAP56 represses the binding of 
excess amount of NP to RNA possibly by transferring trimeric NP. Collectively, we propose that UAP56 
stimulates viral RNP formation through promotion of the assembly of trimeric NP and is important for 
the structural integrity of NP-RNA complex.
The genome of influenza type A viruses is single-stranded RNAs of negative polarity. The viral genome (vRNA) 
exists as ribonucleoprotein (designated vRNP) complexes with heterotrimeric viral RNA-dependent RNA poly-
merases and nucleoprotein (NP)1. NP is one of the basic viral proteins and binds single-stranded RNA without 
sequence specificity. NP is essential to maintain the RNA template in an ordered conformation suitable for viral 
RNA syntheses2–6. Cryo-electron microscopy analysis revealed that the oligomerization of NP is important to 
form a double helical structure with anti-parallel strand of vRNP7,8. Oligomeric NP shows higher RNA binding 
activity than monomeric NP9. Although crystal structures of RNA-free NP showed that NP forms oligomers in 
the crystalline state, a broad size distribution was observed by gel filtration chromatography in solution at phys-
iological salt concentrations9–12, suggesting that NP exists in an equilibrium between monomers and oligomers 
including trimers and tetramers13. Thus, an exact form of NP to be assembled into vRNP remains unknown.
For efficient viral transcription and replication, not only viral factors but also host factors are required. It has 
been reported that RAF-2p48/NPI-5/UAP56, Tat-SF1, and Prp18 function as molecular chaperones for NP to 
recruit NP to the viral RNAs4,14,15. NP chaperones are also required to suppress the aggregation of NP. UAP56 is 
a cellular splicing factor belonging to the DExD-box family of ATP-dependent RNA helicase16. It is reported that 
the newly synthesized viral genome is co-replicationally assembled into RNP complex by UAP563. UAP56 binds 
to NP free of RNA but not NP-RNA complexes15. It is also reported that UAP56 interacts with N-terminal region 
of NP, and NP interacts with C-terminal region of UAP5615. However, the molecular mechanism of the transfer 
of NP to RNA by UAP56 is still unknown.
Here we examined the binding stoichiometry of NP-UAP56 complex using recombinant UAP56 and RNA-free 
NP. We found that UAP56 stably interacts with trimeric NP, and stimulates the assembly of trimers from mono-
meric NP. Gel filtration experiments showed that the molecular size of UAP56-NP complex is more than 440 kDa, 
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suggesting that the complex is composed of 6 molecules of NP and 2 molecules of UAP56. By atomic force 
microscopy (AFM) analysis of NP-UAP56, we found a dumbbell-shaped complex which is considered as two 
trimeric NP connected by UAP56. We also revealed that UAP56 facilitates NP-RNA complex formation without 
excessively oligomerized NP-RNA complexes. Taken together, these results suggest that UAP56 stimulates the 
RNP formation through the assembly of trimeric NP and controls the amount of NP on RNA for the structural 
integrity of NP-RNA complex for efficient viral RNA synthesis.
Results and Discussion
Binding stoichiometry of NP and UAP56 complex. NP-His and GST-UAP56 were expressed in E. coli 
BL21(DE3) strain and purified by Ni-NTA resin and GST resin, respectively (Fig. 1a). The GST tag of UAP56 was 
digested with Prescission protease (Fig. 1a, lane 3). After buffer exchange to a buffer containing 25 mM HEPES-
NaOH (pH 7.0), 150 mM NaCl, 1 mM DTT, and 5% glycerol, purified NP-His and UAP56 were incubated at 
4 °C overnight. The NP-UAP56 complex was partially purified using Sephacryl S-200 gel filtration column, and 
then the NP-UAP56 complex was analyzed by Superose 6 gel filtration column (Fig. 1b). In the absence of NP, 
UAP56 was eluted as a homogenous single peak at elution volume of 1.6 ml, which corresponds to the molecular 
weight of about 100 kDa. Because theoretical molecular weight of UAP56 is 49.8 kDa, this result suggested that 
UAP56 forms a dimer. The elution peak of NP free of UAP56 was found at around 63 kDa, suggesting that NP 
mainly exists as a monomer (theoretical molecular weight is 57.9 kDa). We found that the NP-UAP56 complex 
was recovered as a single peak at elution volume of 1.4 ml, which corresponds to the molecular weight of more 
than 440 kDa. CBB staining of the peak fraction showed that the complex consists of NP and UAP56 at a 3:1 
molar ratio, indicating that UAP56 interacts with trimeric NP (Fig. 1c, lanes 2–4). Similar results were obtained 
by an alternative staining method, called VisPRO™ 5 Minutes Protein Stain Kit, which stains the gel but not the 
protein sample (Supplementary Figure S1). Since the observed molecular weight of NP-UAP56 complex on the 
gel filtration column was around 440 kDa, it is likely that the NP-UAP56 complex is composed of 6 molecules of 
NP and 2 molecules of UAP56 with the theoretical molecular weight of 447 kDa. To confirm the binding of NP to 
Figure 1. Binding stoichiometry of NP-UAP56 complex. (a) SDS-PAGE analysis. The detail of purification 
scheme is described in Methods. Lane 1, molecular size marker; Lane 2, NP-His; Lane 3, UAP56. (b) Gel 
filtration chromatography. NP-UAP56 complex was partially purified using Sephacryl S-200 gel filtration 
column. Then, the purified NP-UAP56 complex (black), UAP56 (red), and NP (blue) were eluted from a 
Superose 6 gel filtration column. The peak positions of protein standards are marked by arrows. (c) NP (300 
ng), UAP56 (300 ng), and NP-UAP56 complex (66, 200, and 600 ng) were separated on 10% SDS-PAGE and 
visualized by CBB staining. (d) UAP56, NP, and NP-UAP56 complex were analyzed by 6% native PAGE in 
0.5 × TBE buffer and visualized by silver staining.
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UAP56, aliquots of the peak fraction were applied to a 6% native PAGE (Fig. 1d). UAP56 is an acidic protein with 
isoelectric point of about 5.4 and can be migrated to the cathode side in native PAGE (Fig. 1d, lane 1), whereas NP 
is hardly migrated to the gel because NP is a highly basic protein with isoelectric point of about 9.6 (Fig. 1d, lane 
2). The NP-UAP56 complex showed a slower migration pattern than UAP56 free of NP, and there is no UAP56 
free of NP (Fig. 1d, lane 3). These results suggest that UAP56 stably interacts with NP.
UAP56 binds to trimeric NP but not monomeric NP. NP consists of head and body domains with a 
long tail loop, formed by residues 402–428, at the outlying part of RNA-binding groove. The interaction of the tail 
loop from one NP molecule with a neighboring subunit is important to form homo-oligomers. Next, to examine 
whether monomeric or oligomeric NP binds to UAP56, we purified a tail loop mutant, R416A, which is a mon-
omeric NP mutant9,12,17. UAP56 was incubated with either wild type or R416A mutant at 4 °C overnight. The 
mixtures were fractionated through chromatography on a gel filtration column, and the fractions were analyzed 
by 10% SDS-PAGE (Fig. 2). We found that UAP56 was recovered with wt NP in the fractions around 440 kDa 
(Fig. 2a), but R416A mutant did not (Fig. 2b). This suggests that UAP56 specifically interacts with trimeric NP. 
It is noted that UAP56 recognizes the N-terminal 188 amino acid residues of NP15, suggesting that the tail loop 
is not the direct binding site for UAP56. It is reported that monomeric NP binds to RNA, and the association of 
additional monomers to the pre-existing monomeric NP-RNA complex leads to higher order oligomers9. This 
stepwise assembly of NP-RNA complex is thought to be a slow process9. In contrast, pre-formed trimeric NP 
interacts rapidly with RNA9. Although our purified NP mainly contains monomeric NP (Fig. 1b), a large part of 
NP interacting with UAP56 was recovered as trimeric NP as shown in Fig. 1b (Fig. 2a, lanes 6–8). Thus, it is quite 
likely that UAP56 promotes the trimer formation of NP, and thereby UAP56 facilitates the transfer of NP to RNA 
as a molecular chaperone.
Next, to demonstrate the protein composition of NP-UAP56 complex, we carried out AFM analyses (Fig. 3). In 
the absence of UAP56, NP was observed as globular proteins which are approximately either 3–4 nm or 12–13 nm 
in length (Fig. 3a and b). According to the crystal structure of NP12, the size of monomeric NP and trimeric NP is 
thought to be approximately 5 nm and 15 nm, respectively. This suggests that the smaller particles are monomeric 
NP, while the bigger ones are trimeric NP. In contrast, NP-UAP56 complex was found as a dumbbell-shaped com-
plex of approximately 40–50 nm in major axis (Fig. 3c and d). Since the size of trimeric NP and UAP56 dimer are 
is approximately 15 nm and 6 nm18 respectively, suggesting that the dumbbell-shaped complex seems to be two 
trimeric NP connected by UAP56 dimer.
UAP56-mediated NP-RNA complex formation. To examine the chaperone activity of the purified 
NP-UAP56 complex, we performed EMSA with [32P]-labeled 53 nt-long (Fig. 4a and b) and 165 nt-long (Fig. 4c) 
model vRNAs, respectively. The formation of NP-RNA complex was stimulated in the presence of UAP56 (Fig. 4a, 
compare lanes 5–7 with lanes 8–10; Fig. 4c, compare lanes 1–3 with lanes 4–6). Further, the migration rate of 
NP-RNA complex in the presence of UAP56 was faster than that without UAP56 (Fig. 4a, compare lane 6 with 
lane 8; Fig. 4b). In the case of 165 nt-long model vRNA, excessively oligomerized NP-RNA complexes that can-
not enter native PAGE were formed in the absence of UAP56 (Fig. 4c, lanes 1–3), whereas the NP-RNA complex 
assembled in the presence of UAP56 successfully migrated to the gel (Fig. 4c, lanes 4–6). It has been proposed 
that NP binds to a replicating RNA, and then additional NP molecules are subsequently recruited by the NP-NP 
oligomerization for the efficient encapsidation of nascent chains5,17. Thus, it is possible that UAP56 modulates the 
self-oligomerization of NP on viral RNAs to assemble the functional RNP complexes by recruiting trimeric NP 
to viral RNAs. To examine whether UAP56 interacts with NP-RNA complex or not, we carried out the western 
blotting using antibodies against UAP56 (Fig. 4d) and His-tag (Fig. 4e) after separating the NP-RNA complex by 
EMSA. UAP56 free of NP was incubated in the absence or presence of 53 nt-long model vRNA, and subjected 
to EMSA (Fig. 4d, lanes 1–6). The migration rate of UAP56 was not changed in the presence of RNA, suggesting 
that the negatively charged UAP56 does not bind to RNA as shown in Fig. 4a (lanes 2–4) and Fig. 4c (lanes 8–10). 
Further, by the addition of RNA to NP-UAP56 complex, UAP56 was not found in NP-RNA complex (compare 
Fig. 4d, lanes 13–15 with Fig. 4e, lanes 13–15) and migrated to the same position as UAP56 free of NP (compare 
Figure 2. UAP56 interacts with trimeric NP but not monomeric NP. Wild type NP (panel A) and R416A 
NP mutant (panel B) were incubated with UAP56, respectively. Each sample was subjected to gel filtration 
chromatography, and the eluted proteins were separated on 10% SDS-PAGE and visualized by CBB staining. 
The peak positions of protein standards are marked by arrows.
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lanes 1–3 with lanes 13–15 in Fig. 4d). This result suggests that NP-UAP56 complex was dissociated by the addi-
tion of RNA as previously proposed15.
In conclusion, UAP56 forms dimer in solution, and the binding stoichiometry of NP-UAP56 complex is a 1:3 
molar ratio, suggesting that UAP56 interacts with trimeric NP. Thus, it is likely that dimerized UAP56 proteins 
bind to trimeric NP, respectively. We also found that UAP56 stimulates trimeric NP formation from monomeric 
NP even at physiological salt concentrations. Therefore, UAP56 facilitates the transfer of NP to viral RNA as a 
molecular chaperone since trimeric NP has higher RNA binding activity than monomeric NP9. In the absence 
of UAP56, monomeric NP first binds to RNA, and the additional monomers randomly bind to the monomeric 
NP on NP-RNA complex, slowly9 (Fig. 5). In contrast, we found that UAP56 represses the binding of an excess 
amount of NP to RNA possibly by transferring trimeric NP (Fig. 5). This is in good agreement with previous 
reports that UAP56 provides functional NP-RNA complex competent for viral RNA synthesis3,15. Taken alto-
gether, we propose that UAP56 simulates NP-RNA complex formation by recruiting trimeric NP and suppresses 
the formation of excessively oligomerized NP-RNA complex as shown in the latter model (Fig. 5). Our findings 
reveal the molecular mechanism of molecular chaperone-dependent ribonucleoprotein complex formation for 
viral RNA synthesis.
Methods
Biological materials. Rabbit anti-UAP56 antibody was prepared as previously described15. Mouse anti-
His antibody was purchased (Nacalai tesque). Plasmids expressing His-tagged NP and UAP56 were constructed 
using pET14b and pGEX-2T as previously described3,15. For the construction of a plasmid expressing R416A 
NP mutant, cDNA containing R416A point mutation was amplified from pET14b-NP by overlap PCR with 
primers 5ʹ-TCAGTACAGGCAAATCTCCCT-3ʹ, 5ʹ-AGGGAGATTTGCCTGTACTGA-3ʹ, 5ʹ-GGGAATTC-
CATATGGCGTCTCAAGGCACCA-3ʹ, and 5ʹ-CCGGTCGACTAGTGATGATGATGATGATGGCCATTGTCG-
TACTCCTCTGCATTGTCTCCG-3ʹ. The cDNA was cloned into pET14b at Nco I and Nde I sites.
Preparation of recombinant proteins. Plasmids expressing NP-His, R416A NP-His, and GST-UAP56, 
were transformed into BL21(DE3) strain (Stratagene), respectively. The proteins were expressed in LB medium 
for 16 h at 18 °C after induction with 0.2 mM IPTG. For NP-His and R416A NP-His, the harvested cells were sus-
pended in lysis buffer A (25 mM HEPES-NaOH [pH 7.9], 500 mM NaCl, 30 mM imidazole, and 5% glycerol) con-
taining 0.1% Triton X-100 and 1 mM PMSF. After lysis by sonication, the lysates were centrifuged at 20,000 × g for 
30 min. The supernatants were filtrated with a 0.45-μm filter and subjected to His-tag purification using Ni-NTA 
agarose beads (GE healthcare). After washing with five column volumes of buffer A, NP proteins were eluted in 
Figure 3. NP-UAP56 was observed to be a dumbbell-shaped complex by AFM. NP alone (panels a and b) and 
NP-UAP56 complex (panels C and D) were subjected to AFM analysis, respectively. Monomeric NP, trimeric 
NP, and NP-UAP56 particles are indicated by yellow, blue, and red circles, respectively (panels A and C). Scale 
bar, 100 nm. The size distribution of NP or NP-UAP56 particles in major axis is shown in panels B and D. Solid 
lines represent a Gaussian fit.
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buffer A containing 300 mM imidazole. To remove the bacterial RNA bound to NP, the NP lysates were treated 
with RNase A before purification and washed with buffer A containing 1.5 M NaCl during purification. Purified 
NP with a ratio of the absorbance at 260 nm to that at 280 nm of between 0.57 and 0.59 was used for this study. 
For GST-UAP56, the cell pellet was resuspended in lysis buffer B (25 mM HEPES-NaOH [pH 7.3], 500 mM 
NaCl, 1 mM DTT, and 5% glycerol) containing 0.1% Triton X-100 and 1 mM PMSF. After sonication, the lysates 
were centrifuged at 20,000 × g for 30 min. The supernatants were filtrated with a 0.45-μm filter and subjected to 
GST-tag purification using glutathione Sepharose beads (GE healthcare). After washing with 5 column volumes 
of buffer B, GST-UAP56 immobilized on the resin was digested with an appropriate amount of PreScission pro-
tease for 12 h at 4 °C. UAP56 without GST tag was collected in the flow through fraction.
Gel filtration analysis. After buffer exchange of purified NP and UAP56 to buffer C (25 mM HEPES-NaOH 
[pH 7.0], 150 mM NaCl, 1 mM DTT, and 5% glycerol) using a desalting column (HiPreP 26/10 Desalting, GE 
Healthcare), purified NP and UAP56 were mixed at a 1:1 molar ratio, and were incubated at 4 °C for overnight. 
The NP-UAP56 complex was purified by a gel filtration chromatography using the HiPrep 16/60 Sephacryl S-200 
HR column (GE Healthcare) on AKTA system (GE Healthcare) or Superose 6 PC 3.2/30 column on SMART 
system (Amersham Pharmacia) in buffer C. The SDS-PAGE gel of NP-UAP56 was visualized by either CBB stain-
ing or VisPRO™ 5 Minutes Protein Stain Kit (Visual Protein). The band intensities were measured by ImageJ 
software.
AFM analysis. NP alone and NP-UAP56 complex were subjected to AFM analysis in air at room temper-
ature (Bruker Nanoscope VIII, Bruker). The system was operated in tapping mode with a 100-μm scanner. 
Probes made of a single silicon crystal with a cantilever length of 129 µm and spring constant of 33–62 N/m 
Figure 4. UAP56 mediates the NP-RNA complex formation as a molecular chaperone. (a) 0.5 pmol of32 
P-labeled 53 nt-long model vRNA was incubated with increasing amounts (0.8 pmol, lanes 2, 5, and 8; 2.4 pmol, 
lanes 3, 6, and 9; 7.2 pmol, lanes 4, 7, and 10) of UAP56 (lanes 2–4), NP (lanes 5–7) or NP-UAP56 complex 
(lanes 8–10) at 30 °C for 30 min. The samples were analyzed by 6% native PAGE in 0.5 × TBE buffer and 
visualized by autoradiography. (b) The signal intensities of lanes 6 and 8 in panel A were measured by ImageJ 
software along the dashed arrows shown within the panel A. (c) 0.5 pmol of 32P-labeled 165 nt-long model 
vRNA was incubated with increasing amounts (0.8 pmol, lanes 1, 4, and 8; 2.4 pmol, lanes 2, 5, and 9; 7.2 pmol, 
lanes 3, 6, and 10) of UAP56 (lanes 8–10), NP (lanes 1–3) or NP-UAP56 complex (lanes 4–6) at 30 °C for 30 min. 
The samples were analyzed by 6% native PAGE in 0.5 × TBE buffer and visualized by autoradiography. (d and e) 
NP (0.6 pmol, 1.8 pmol, and 5.4 pmol), UAP56 (0.6 pmol, 1.8 pmol, and 5.4 pmol) or NP-UAP56 complex (0.6 
pmol, 1.8 pmol, and 5.4 pmol) was incubated with 0.5 pmol of 53 nt-long vRNA. UAP56 (0.6 pmol, 1.8 pmol, 
and 5.4 pmol), or NP-UAP56 (0.6 pmol, 1.8 pmol, and 5.4 pmol) was also incubated without 53 nt-long vRNA. 
The samples were separated on 6% native PAGE in 0.5 × TBE buffer, and the gels were subjected to western 
blotting using anti-UAP56 (panel D) and anti-His-tag (panel E) antibodies, respectively.
www.nature.com/scientificreports/
6ScIenTIFIc REPORts | 7: 14053  | DOI:10.1038/s41598-017-13784-4
(OMCL-AC160TS-W2, Olympus) were used for imaging. Data were collected in the height mode. Images were 
captured in 512 × 512 pixels and the captured images were flattened and plane-fitted before analysis. The size of 
the particles was calculated with a correction for tip effect as previously reported19.
Electrophoretic mobility shift assay (EMSA). Increasing amounts (0.8 pmol, 2.4 pmol, and 7.2 
pmol) of NP or NP-UAP56 complex were incubated with 0.5 pmol of32P-labeled 53 nt-long model viral 
genome (5′-AGUAGAAACAAGGGUGUUUUUUCAUAUCAUUUAAACUUCACCCUGCUUUUGCU-3
′) or 165 nt-long model viral genome (5′- AGUAGAAACAAGGUCGUUUUUAAACUAUUCGACACUAA 
UUGAUGGCCAUCCGAAUUUAUGGUCCACGGUGGUUUUUGUGAGUAUCUCGCGGGUGCGA 
GACUGCGACAUUAGAUUUCUUAGUUCUUUUAUUCUUUCCAUAUUGAAUAUAAUUGACC 
UGCUUUCGCU-3′) in a buffer containing 50 mM HEPES-NaOH (pH 8.0), 100 mM NaCl, 5 mM MgCl2, 1 mM 
DTT, and 5% glycerol at 30 °C for 30 min. The samples were applied to a 6% native PAGE in 0.5 × TBE buffer and 
visualized by autoradiography.
Western blotting assay. UAP56 (0.6 pmol, 1.8 pmol, and 5.4 pmol) or NP-UAP56 complex (0.6 pmol, 
1.8 pmol, and 5.4 pmol) was incubated with 0.5 pmol of 53 nt-long model vRNA in a buffer containing 50 mM 
HEPES-NaOH (pH 8.0), 100 mM NaCl, 5 mM MgCl2, 1 mM DTT, and 5% glycerol. The samples were separated 
on 6% native PAGE in 0.5 × TBE buffer, and the gels were subjected to western blotting using anti-UAP56 and 
anti-His-tag antibodies, respectively.
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